eFinder

eFinder

Home › Market Analysis › Article

Friday's big stock stories: What’s likely to move the market in the next trading session

Cnbc · · 684 words · By Jason Gewirtz
Market Analysis Financial Education Promotion
open_in_new Read the original article: https://www.cnbc.com/2026/05/21/fridays-big-stock-stories-whats-likely-to-move-t…

psychologyDetected Techniques

warning
Loaded Language 70% confidence
Using words with strong emotional connotations to influence an audience.
warning
Glittering Generalities 60% confidence
Using vague, emotionally appealing phrases ('freedom', 'justice') without specifics.

fact_checkFact-Check Results

44 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

schedule Pending 34
info Single Source 6
help Insufficient Evidence 3
cancel Disputed 1
cancel
“The influential meeting of the American Society of Clinical Oncology begins on Friday.”
DISPUTED
The evidence provides conflicting dates for the ASCO meeting. One source states it was scheduled for May 29 to June 2, while another states it takes place June 3–7. This contradicts the claim that it begins on 'Friday' without a specific date, as the start dates vary across sources.
travel_explore
web search NEUTRAL — Make JCO Central your hub to recharge, network, and engage in editor-led education. Learn publishing best practices, explore global oncology trends, and connect daily with our editorial team.
https://www.asco.org/
travel_explore
web search NEUTRAL — Due to COVID-19 (coronavirus), the American Society of Clinical Oncology (ASCO) Annual Meeting will now occur using a virtual format instead of the in-person meeting that had been scheduled to take pl…
https://www.onclive.com/view/asco-meeting-goes-virtual-due-t…
travel_explore
web search NEUTRAL — Among those presenting at this year's American Society of Clinical Oncologists meeting are physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center. The meeting takes…
https://www.newswise.com/articles/newyork-presbyterian-colum…
info
“The NYSE Arca Biotechnology Index (.BTK) is up nearly 4% in May.”
SINGLE SOURCE
While web results confirm the existence of the NYSE Arca Biotechnology Index (.BTK), none of the provided search results contain the specific percentage change for the month of May.
travel_explore
web search NEUTRAL — Overvalued Stocks. ARCA Biotechnology (BTK). Find here information about the ARCA Biotechnology index (BTK). Assess the ARCA Biotechnology stock price and overall performance.
https://www.investing.com/indices/arca-biotechnology
travel_explore
web search NEUTRAL — Get historical data for the NYSE Arca Biotechnology Index (^BTK) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.
https://finance.yahoo.com/quote/^BTK/history/
travel_explore
web search NEUTRAL — BTK | A complete NYSE Arca Biotechnology Index index overview by MarketWatch. View stock market news, stock market data and trading information.
https://www.marketwatch.com/investing/index/btk
info
“It has gained about 33% in the past year.”
SINGLE SOURCE
Search results confirm the index exists and provide links to historical data, but the specific figure of a 33% gain over the past year is not present in the provided evidence snippets.
travel_explore
web search NEUTRAL — Get historical data for the NYSE Arca Biotechnology Index (^BTK) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.
https://finance.yahoo.com/quote/^BTK/history/
travel_explore
web search NEUTRAL — Overvalued Stocks. ARCA Biotechnology (BTK). Find here information about the ARCA Biotechnology index (BTK). Assess the ARCA Biotechnology stock price and overall performance.
https://www.investing.com/indices/arca-biotechnology
travel_explore
web search NEUTRAL — BTK | A complete NYSE Arca Biotechnology Index index overview by MarketWatch. View stock market news, stock market data and trading information.
https://www.marketwatch.com/investing/index/btk
info
“The index is down 5.25% from the January high.”
SINGLE SOURCE
The evidence provides general overviews and chart links for the .BTK index, but does not state the specific percentage drop from the January high.
travel_explore
web search NEUTRAL — Find the latest information on NYSE Arca Biotechnology Index (^BTK) including data, charts, related news and more from Yahoo Finance.
https://finance.yahoo.com/quote/^BTK/
travel_explore
web search NEUTRAL — BTK | A complete NYSE Arca Biotechnology Index index overview by MarketWatch. View stock market news, stock market data and trading information.
https://www.marketwatch.com/investing/index/btk
travel_explore
web search NEUTRAL — Overvalued Stocks. ARCA Biotechnology (BTK). Find here information about the ARCA Biotechnology index (BTK). Assess the ARCA Biotechnology stock price and overall performance.
https://www.investing.com/indices/arca-biotechnology
info
“The State Street SPDR S & P Biotech ETF (XBI) is down 4.6% from the April 17 high.”
SINGLE SOURCE
The evidence confirms the existence of the XBI ETF, but does not provide the specific percentage decrease from the April 17 high.
travel_explore
web search NEUTRAL — Find the latest State Street SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing.This Biotech ETF Is Still Well Below It…
https://finance.yahoo.com/quote/XBI/
travel_explore
web search NEUTRAL — Get detailed information about the SPDR S&P Biotech ETF. View the current XBI stock price chart, historical data, premarket price, dividend returns and more.
https://www.investing.com/etfs/spdr-s-p-biotech
travel_explore
web search NEUTRAL — Key Features. The State Street® SPDR® S&P® Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Biotechnolog…
https://www.ssga.com/us/en/intermediary/etfs/state-street-sp…
info
“The ETF is up 1% in May.”
SINGLE SOURCE
The evidence mentions the XBI ETF and some technical analysis, but does not confirm a 1% increase in May.
travel_explore
web search NEUTRAL — Find the latest State Street SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing.Inception Date. More about State Street…
https://finance.yahoo.com/quote/XBI/
travel_explore
web search NEUTRAL — About State Street SPDR S&P Biotech ETF.Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. The index is rebalanced quarterly. Prior to Oct. 31, 2025 …
https://www.tradingview.com/symbols/AMEX-XBI/
travel_explore
web search NEUTRAL — Top Stories On State Street SPDR S&P Biotech ETF.May. 1, 2026 at 3:08 p.m. ET by Investor's Business Daily. Technical Analysis Gilead Sciences Crosses Critical Breakout Level. The Stock Can Gain 35% F…
https://www.marketwatch.com/investing/fund/xbi
help
“It has gained 67% in the past year.”
INSUFFICIENT EVIDENCE
The claim states a 67% gain in the past year, but a specific news source (24/7 Wall St.) explicitly states that the XBI gained +40.32% over the past year, directly contradicting the 67% figure.
travel_explore
web search NEUTRAL — State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) retur…
https://247wallst.com/investing/2026/03/31/biotech-stocks-ar…
travel_explore
web search NEUTRAL — Find the latest State Street SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing.Locking In A Quick Gain In This Biotech…
https://finance.yahoo.com/quote/XBI/
travel_explore
web search NEUTRAL — | XBI U.S.: NYSE Arca. State Street SPDR S&P Biotech ETF.Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's Why.
https://www.marketwatch.com/investing/fund/xbi
info
“The iShares Biotechnology ETF (IBB) is off 6% from the January high.”
SINGLE SOURCE
The evidence confirms the existence and purpose of the IBB ETF, but does not provide the specific percentage drop from the January high.
travel_explore
web search NEUTRAL — The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.Current performance may be lower or higher than the perform…
https://www.ishares.com/us/products/239699/ishares-biotechno…
travel_explore
web search NEUTRAL — iShares Biotechnology ETF Overview iShares / Health. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its asset…
https://finance.yahoo.com/quote/IBB/
travel_explore
web search NEUTRAL — Get detailed information about the iShares Biotechnology ETF ETF. View the current IBB stock price chart, historical data, premarket price, dividend returns and more.
https://www.investing.com/etfs/ishares-nasdaq-biotech
help
“It's little changed in May, and has gained about 39% in a year.”
INSUFFICIENT EVIDENCE
No evidence was found for this claim in the provided search results.
help
“S & P Health Care Sector, which is down 7.5% from the February high.”
INSUFFICIENT EVIDENCE
No evidence was found for this claim in the provided search results.
schedule
“It has advanced 1% in a month, and it has gained around 13% in a year.”
PENDING
schedule
“The Pharma, Biotech and Life Sciences S & P Industry Group is off 7.5% from the February high.”
PENDING
schedule
“It has jumped 27% in a year.”
PENDING
schedule
“The S & P Real Estate sector has added about 3% in four days.”
PENDING
schedule
“The S & P Real Estate Sector has risen about 11% in a year.”
PENDING
schedule
“The S & P 500 has jumped 27% in a year.”
PENDING
schedule
“American Tower has gained 7.7% in the past four days.”
PENDING
schedule
“It's down 21% from the 52-week high reached in July.”
PENDING
schedule
“The stock has a current dividend yield of about 3.8%.”
PENDING
schedule
“Its business focuses on leasing land for cell phone towers.”
PENDING
schedule
“Alexandria Real Estate has advanced 6.4% in four days.”
PENDING
schedule
“Shares are down 46% from the 52-week high hit in September.”
PENDING
schedule
“The stock has a current yield of 8.5%.”
PENDING
schedule
“Much of the business is invested in labs leased to clients in the life sciences industry.”
PENDING
schedule
“Crown Castle has added 6.2% week to date.”
PENDING
schedule
“The stock is down 20% from the July high.”
PENDING
schedule
“The current dividend yield is 4.6%.”
PENDING
schedule
“The company is a competitor of American Tower.”
PENDING
schedule
“the U.S. government said it was giving $2 billion to a group of companies in the quantum computing space.”
PENDING
schedule
“Rigetti Computing is up again after hours, almost 7%.”
PENDING
schedule
“The stock picked up 30% in regular trading.”
PENDING
schedule
“It is down 62% from the October high.”
PENDING
schedule
“Quantum Computing is up 5% after hours.”
PENDING
schedule
“The stock jumped almost 20% during the regular session.”
PENDING
schedule
“It is off 38% from the October high.”
PENDING
schedule
“D-Wave Quantum is up 7% after hours.”
PENDING
schedule
“The stock was up 33% on Thursday.”
PENDING
schedule
“The stock is down 45% from the October high.”
PENDING
schedule
“IonQ was up 12% on Thursday.”
PENDING
schedule
“The stock is down 30% from the October high.”
PENDING
schedule
“Arqit Quantum was up 25% in the session.”
PENDING
schedule
“It is off 73% from the October high.”
PENDING
schedule
“IBM is in the space, too. It was up 12% during the session.”
PENDING
schedule
“It is down 22% from the November high.”
PENDING
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.